Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||
| Net Income | 114,800 | 152,600 | 142,400 |
| Depreciation Amortization | 52,600 | 57,600 | 51,100 |
| Income taxes - deferred | -700 | N/A | N/A |
| Accounts receivable | -5,400 | N/A | N/A |
| Accounts payable and accrued liabilities | 7,800 | N/A | N/A |
| Other Working Capital | -24,500 | 9,590 | -68,300 |
| Other Operating Activity | 2,500 | -17,190 | 14,400 |
| Operating Cash Flow | $147,100 | $202,600 | $139,600 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -37,900 | -40,300 | -35,800 |
| Net Acquisitions | -2,200 | 0 | 0 |
| Other Investing Activity | 0 | 0 | -3,700 |
| Investing Cash Flow | $-40,100 | $-40,300 | $-39,500 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -52,700 | N/A | N/A |
| Other Financing Activity | -59,800 | -133,900 | -115,100 |
| Financing Cash Flow | $-112,500 | $-133,900 | $-115,100 |
| Exchange Rate Effect | 1,600 | -600 | 800 |
| Beginning Cash Position | 47,900 | 20,100 | 34,300 |
| End Cash Position | 44,000 | 47,900 | 20,100 |
| Net Cash Flow | $-3,900 | $27,800 | $-14,200 |
| Free Cash Flow | |||
| Operating Cash Flow | 147,100 | 202,600 | 139,600 |
| Capital Expenditure | -37,900 | N/A | N/A |
| Free Cash Flow | 109,200 | 202,600 | 139,600 |